Atlas Trials

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Clinical trial NCT06660368 · RECRUITING

Trial details

NCT number
NCT06660368
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Start date
2024-11-26
Primary completion
2027-11-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.